Nyxoah (NYXH) Non-Current Deffered Revenue (2024 - 2025)
Nyxoah's quarterly Non-Current Deffered Revenue came in at $792713.6 in Q4 2025, up 57.17% year-on-year from $504377.0 in Q4 2024, and up 57.17% quarter-over-quarter from $504377.0 in Q4 2024.
Nyxoah has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $792713.6 in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deffered Revenue rose 57.17% year-over-year to $792713.6; the trailing twelve-month figure through Dec 2025 stood at $792713.6 (up 57.17% YoY), and the FY2025 full-year result was $792713.6, up 57.17% from the prior year.
- Non-Current Deffered Revenue for Q4 2025 stood at $792713.6, up from $504377.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $792713.6 in Q4 2025, with the low at $504377.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 163.15 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 11.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 206.40 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Nyxoah | 1,248.49 | 1,248.49 | 4.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 792,713.63 |
| Dec 31, 2024 | 504,377.03 |